SEARCH

SEARCH BY CITATION

References

  • Abecasis, G.R. & Cookson, W.O. (2000) GOLD – graphical overview of linkage disequilibrium. Bioinformatics 16, 182183.
  • Bray, P.J. & Cotton, R.G. (2003) Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat 21, 557568.
  • Bronnegard, M., Werner, S. & Gustafsson, J.A. (1986) Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom. J Clin Invest 78, 12701278.
  • Buckley, T.M. & Schatzberg, A.F. (2005) On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90, 31063114.
  • Calis, M., Gokce, C., Ates, F., Ulker, S., Izgi, H.B., Demir, H., Kirnap, M., Sofuoglu, S., Durak, A.C., Tutus, A. & Kelestimur, F. (2004) Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest 27, 4246.
  • Cleare, A.J. (2003) The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 24, 236252.
  • Cleare, A.J. (2004) The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab 15, 5559.
  • De La Vega, F.M., Gordon, D., Su, X., Scafe, C., Isaac, H., Gilbert, D.A. & Spier, E.G. (2005a) Power and sample size calculations for genetic case/control studies using gene-centric SNP maps: applications to human chromosomes 6, 21, and 22 in three populations. Hum Hered 60, 4360
  • De La Vega, F.M., Isaac, H., Collins, A., Scafe, CR., Halldorsson, B.V., Su, X., Lippert, R.A., Wang, Y., Laig-Webster, M., Koehler, R.T., Ziegle, J.S., Wogan, L.T., Stevens, J.F., Leinen, K.M., Olson, S. J., Guegler, K.J., You, X., Xu, L.H., Hemken, H.G., Kalush, F., Itakura, M., Zheng, Y., De The, G., O’Brien, S.J., Clark, A.G., Istrail, S., Hunkapiller, M.W., Spier, E.G. & Gilbert, D.A. (2005b) The linkage disequilibrium maps of three human chromosomes across four populations reflect their demographic history and a common underlying recombination pattern. Genome Res 15, 454462.
  • Demitrack, M.A. (1998) Neuroendocrine aspects of chronic fatigue syndrome: a commentary. Am J Med 105, 11S14S.
  • DeRijk, R.H., Schaaf, M. & De Kloet, E.R. (2002) Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 81, 103122.
  • Devlin, B. & Risch, N. (1995) A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29, 311322.
  • Freeman, R. (2002) The chronic fatigue syndrome is a disease of the autonomic nervous system. Sometimes. Clin Auton Res 12, 231233.
  • Fukuda, K., Straus, S.E., Hickie, I., Sharpe, M.C., Dobbins, J.G. & Komaroff, A. (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121, 953959.
  • Haddad, J.J., Saade, N.E. & Safieh-Garabedian, B. (2002) Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 133, 119.
  • Hawkins, G.A., Amelung, P.J., Smith, R.S., Jongepier, H., Howard, T.D., Koppelman, G. H., Meyers, D.A., Bleecker, E.R. & Postma, D.S. (2004) Identification of polymorphisms in the human glucocorticoid receptor gene (NR3C1) in a multi-racial asthma case and control screening panel. DNA Seq 15, 167173.
  • Heim, C., Ehlert, U. & Hellhammer, D.H. (2000) The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25, 135.
  • Heim, C., Plotsky, P.M. & Nemeroff, C.B. (2004) Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 29, 641648.
  • Juruena, M.F., Cleare, A.J. & Pariante, C.M. (2004) The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression. Rev Bras Psiquiatr 26, 189201.
  • Kaushik, N., Fear, D., Richards, S.C., McDermott, C.R., Nuwaysir, E.F., Kellam, P., Harrison, T.J., Wilkinson, R.J., Tyrrell, D.A., Holgate, S.T. & Kerr, J.R. (2005) Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 58, 826832.
  • Kunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., Yuuki, N., Otsubo, T., Oshima, A., Kudo, K., Inoue, T., Kitaichi, Y., Shirakawa, O., Isogawa, K., Nagayama, H., Kamijima, K., Nanko, S., Kanba, S., Higuchi, T. & Mikuni, M. (2006) Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology 31, 212220.
  • Lewontin, R.C. (1995) The detection of linkage disequilibrium in molecular sequence data. Genetics 140, 377388.
  • Narita, M., Nishigami, N., Narita, N., Yamaguti, K., Okado, N., Watanabe, Y. & Kuratsune, H. (2003) Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun 311, 264266.
  • Pariante, C.M. & Miller, A.H. (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatr 49, 391404.
  • Powell, R., Ren, J., Lewith, G., Barclay, W., Holgate, S. & Almond, J. (2003) Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin Exp Allergy 33, 14501456.
  • Raison, C.L. & Miller, A.H. (2003) When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatr 160, 15541565.
  • Rajeevan, M.S., Swan, D.C., Nisenbaum, R., Lee, D.R., Vernon, S.D., Ruffin, M. T., Horowitz, I.R., Flowers, L.C., Kmak, D., Tadros, T., Birdsong, G., Husain, M., Srivastava, S. & Unger, E.R. (2005) Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer 115, 114120.
  • Ranade, K., Chang, M.S., Ting, C.T., Pei, D., Hsiao, C.F., Olivier, M., Pesich, R., Hebert, J., Chen, Y.D., Dzau, V.J., Curb, D., Olshen, R., Risch, N., Cox, D.R. & Botstein, D. (2001) High-throughput genotyping with single nucleotide polymorphisms. Genome Res 11, 12621268.
  • Reeves, W.C., Lloyd, A., Vernon, S.D., Klimas, N., Jason, L.A., Bleijenberg, G., Evengard, B., White, P.D., Nisenbaum, R. & Unger, E.R. (2003) Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 3, 25.
  • Reeves, W., Wagner, D., Nisenbaum, R., Jones, J., Gurbaxani, B., Solomon, L., Papanicolaou, D., Unger, E., Vernon, S. & Heim, C. (2005) Chronic fatigue syndrome – a clinically empirical approach to its definition and study. BMC Medicine 3, 19.
  • Reyes, M., Nisenbaum, R., Hoaglin, D.C., Unger, E.R., Emmons, C., Randall, B., Stewart, J. A., Abbey, S., Jones, J.F., Gantz, N., Minden, S. & Reeves, W.C. (2003) Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 163, 15301536.
  • Reynolds, K.J., Vernon, S.D., Bouchery, E. & Reeves, W.C. (2004) The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc 2, 4.
  • Robbins, L., Cottler, L., Bucholz, K. & Compton, W. (1995) Diagnostic Interview Schedule for DSM-IV (DIS-IV). Washington University, St. Louis, MO.
  • Ronaghi, M. (2003) Pyrosequencing for SNP genotyping. Methods Mol Biol 212, 189195.
  • Schaaf, M.J. & Cidlowski, J.A. (2002) AUUUA motifs in the 3′ UTR of human glucocorticoid receptor alpha and beta mRNA destabilize mRNA and decrease receptor protein expression. Steroids 67, 627636.
  • Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. & Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70, 425434.
  • Smets, E.M., Garssen, B., Bonke, B. & De Haes, J.C. (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39, 315325.
  • Smith, J., Fritz, E. L., Kerr, J.R., Cleare, A.J., Wessely, S. & Mattey, D.L. (2005) Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. J Clin Pathol 58, 860863.
  • Steinau, M., Unger, E.R., Vernon, S.D., Jones, J.F. & Rajeevan, M.S. (2004) Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med 82, 750755.
  • Stevens, A., Ray, D.W., Zeggini, E., John, S., Richards, H.L., Griffiths, C.E. & Donn, R. (2004) Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J Clin Endocrinol Metab 89, 892897.
  • Swaab, D.F., Bao, A.M. & Lucassen, P. J. (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4, 141194.
  • Torpy, D.J., Bachmann, A.W., Gartside, M., Grice, J.E., Harris, J.M., Clifton, P., Easteal, S., Jackson, R.V. & Whitworth, J.A. (2004) Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism. Endocr Res 30, 417429.
  • Torpy, D.J., Bachmann, A.W., Grice, J.E., Fitzgerald, S.P., Phillips, P.J., Whitworth, J.A. & Jackson, R.V. (2001) Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. J Clin Endocrinol Metab 86, 36923700.
  • Turner, J.D. & Muller, C.P. (2005) Structure of the glucocorticoid receptor (NR3C1) gene 5′ untranslated region: identification, and tissue distribution of multiple new human exon 1. J Mol Endocrinol 35, 283292.
  • Unger, E.R., Nisenbaum, R., Moldofsky, H., Cesta, A., Sammut, C., Reyes, M. & Reeves, W. C. (2004) Sleep assessment in a population-based study of chronic fatigue syndrome. BMC Neurol 4, 6.
  • Van West, D., Van Den Eade, F., Del Favero, J., Souery, D., Norrback, K.F., Van Duijn, C., Sluijs, S., Adolfsson, R., Mendlewicz, J., Deboutte, D., Van Broeckhoven, C. & Claes, S. (2005) Glucocorticoid Receptor Gene-Based SNP Analysis in Patients with Recurrent Major Depression. Neuropsychopharmacology 31, 6207.
  • Vernon, S.D., Unger, E.R., Dimulescu, I.M., Rajeevan, M. & Reeves, W.C. (2002) Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 18, 193199.
  • Vladutiu, G.D. & Natelson, B.H. (2004) Association of medically unexplained fatigue with ACE insertion/deletion polymorphism in Gulf War veterans. Muscle Nerve 30, 3843.
  • Wagner, D., Nisenbaum, R., Heim, C., Jones, J.F., Unger, E.R., and Reeves, W.C. (2005). Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr 3, 8.
  • Ware, J.E. & Sherbourne, C.D. (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30, 473483.
  • Westfall, P.H. & Young, S.S. (1993) Resampling-Based Multiple Testing. John Wiley & Sons, Inc., New York.
  • Wust, S., Federenko, I.S., Van Rossum, E.F., Koper, J.W., Kumsta, R., Entringer, S. & Hellhammer, D.H. (2004a) A psychobiological perspective on genetic determinants of hypothalamus-pituitary-adrenal axis activity. Ann N Y Acad Sci 1032, 5262.
  • Wust, S., Van Rossum, E.F., Federenko, I.S., Koper, J.W., Kumsta, R. & Hellhammer, D.H. (2004b) Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 89, 565573.